1.
Tangprasertchai NS, Di Felice R, Zhang X, et al. CRISPR-Cas9 Mediated DNA Unwinding Detected Using Site-Directed Spin Labeling. ACS Chem Biol. 2017;12(6):1489-1493. doi:10.1021/acschembio.6b01137.
1.
Trevino AE, Zhang F. Genome editing using Cas9 nickases. Methods Enzymol. 2014;546:161-74. doi:10.1016/B978-0-12-801185-0.00008-8.
1.
Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34(2):184-91. doi:10.1038/nbt.3437.
1.
Cong L, Zhang F. Genome engineering using CRISPR-Cas9 system. Methods Mol Biol. 2015;1239:197-217. doi:10.1007/978-1-4939-1862-1_10.
1.
Tai DJC, Ragavendran A, Manavalan P, et al. Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR. Nat Neurosci. 2016;19(3):517-22. doi:10.1038/nn.4235.
1.
Woods IG, Schier AF. Targeted mutagenesis in zebrafish. Nat Biotechnol. 2008;26(6):650-1. doi:10.1038/nbt0608-650.
1.
Konermann S, Brigham MD, Trevino AE, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517(7536):583-8. doi:10.1038/nature14136.
1.
Lu TK, Chandrasegaran S, Hodak H. The Era of Synthetic Biology and Genome Engineering: Where No Man Has Gone Before. J Mol Biol. 2016;428(5 Pt B):835-6. doi:10.1016/j.jmb.2016.01.025.
1.
Moffat J, Grueneberg DA, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124(6):1283-98. doi:10.1016/j.cell.2006.01.040.
1.
Cox DBT, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21(2):121-31. doi:10.1038/nm.3793.